Dual antiplatelet therapy for heart disease

Circulation

Volumn 129, Issue 21, 2014, Pages

  Carreras, Edward T ^a   Mega, Jessica L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; IBUPROFEN; PRASUGREL; TICAGRELOR; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOT; CORONARY ARTERY OBSTRUCTION; DUAL ANTIPLATELET THERAPY; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART PERFUSION; HUMAN; NOTE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; DRUG THERAPY, COMBINATION; HEART DISEASES; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 84901447177     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.004305     Document Type: Note

References (2)

1. Atherosclerosis. National Heart, Lung, and Blood Institute; National Institutes of Health; U. S. Department of Health and Human Services. 2013. https //www. nhlbi. nih. gov/ health/health-topics/topics/atherosclerosis. Accessed May 7, 2014.
2. Patient Information Atherosclerosis (The Basics). In Basow DS, ed. UpToDate, Waltham, MA UpToDate; 2013. www. uptodate. com.